Interventional Cardiology News and Research

RSS

Frequent TAVR to replace damaged aortic heart valve improves patient outcomes

The more frequently a hospital performs a minimally invasive technique called transcatheter aortic valve replacement, or TAVR, to replace a damaged aortic heart valve, the better patients fare, on average, immediately after the procedure, researchers reported at the American College of Cardiology's 65th Annual Scientific Session.

4 Apr 2016

Study suggests need for better strategy to reduce fatalities after non-surgical treatment for blocked arteries

Despite the successful adoption of modern techniques, new research from the Universities of Keele and Manchester suggests more can be done to reduce fatalities following a non-surgical treatment for blocked arteries.

21 Mar 2016

Seven easy ways to reduce heart disease risk and be heart-healthy

It's no secret that heart disease is the leading cause of death for adult men and women in this country. It kills one of every four people. While many of us associate February with red-ruffled hearts and chocolate candy for Valentine's Day, it's also "American Heart Month" to raise awareness of the importance of making healthy lifestyle choices to improve overall heart health.

14 Feb 2016

Argon Medical Devices completes acquisition of three vascular products from Rex Medical

Argon Medical Devices, Inc. announced the completed acquisition of three vascular products from Rex Medical, LLC. The OptionELITE Retrievable Vena Cava Filter, CLEANER Rotational Thrombectomy System, and UltraStream Chronic Hemodialysis Catheter are now wholly owned by Argon Medical Devices, Inc.

5 Jan 2016

Heart attack patients with bypass history more likely to have delayed treatment

Heart attack patients who had previously undergone cardiac bypass surgery are about twice as likely to have a delay in receiving angioplasty, or another form of revascularization, compared to heart attack patients who had no history of bypass surgery or previous angioplasty.

31 Dec 2015

Restoring blood flow quickly after heart attack symptoms appear may help reduce heart damage

While hospitals have made strides in reducing the time it takes to treat heart attack patients once they arrive at the hospital, patient delays recognizing symptoms and seeking treatment are associated with increased damage to the heart, according to a study published online today in JACC: Cardiovascular Interventions.

29 Dec 2015

Cardiologists successfully use virtual reality device to treat chronically blocked right coronary artery

Virtual reality (VR) has potential to revolutionize some aspects of medicine and healthcare. Several medical specialties are already using it to train physicians and assist diagnosis and it also has potential for treatment. A group of cardiologists has now successfully used a VR device to guide the opening up (revascularization) of a chronically blocked right coronary artery.

20 Nov 2015

UT Southwestern named one of nation's 'Most Connected Hospitals' for 2015-2016

UT Southwestern Medical Center has been ranked one of the "Most Connected Hospitals" for 2015-2016 by U.S. News & World Report based on its commitment to the use of digital technology in health care.

12 Nov 2015

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

New Haven Pharmaceuticals, Inc. today announced new study data that shows the company's FDA-approved drug DURLAZA delivers sustained antiplatelet control for a full 24-hour period in high-risk patients.

10 Nov 2015

Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

Boston Scientific has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio-based developer of endovascular and interventional cardiology technologies.

10 Nov 2015

UAB performs life-saving TAVR procedure on Selma resident

In the late 1990s, Earnest Tate was named the first black police chief of Selma, Alabama. Nearly 20 years later, Tate is retired and works on his family farm in the city where he made history.

31 Oct 2015

LEADERS FREE clinical trial demonstrates superior safety, efficacy for BioFreedom compared with bare-metal stent

Biosensors International Group, Ltd., a developer, manufacturer and marketer of innovative medical devices, announced today that the LEADERS FREE clinical trial demonstrated superior safety and efficacy for BioFreedom compared with a bare-metal stent (BMS).

15 Oct 2015

Boston Scientific closes additional financing with MValve Technologies

Boston Scientific Corporation today announced that it has closed on an additional round of financing with MValve Technologies Ltd., a developer of a percutaneous mitral valve replacement system, designed to work with the Boston Scientific LOTUS Valve, creating a unique mitral regurgitation (MR) treatment solution.

8 Oct 2015

UT Southwestern's William P. Clements Jr. University Hospital receives UHC's Rising Star Quality Leadership award

UT Southwestern Medical Center's William P. Clements Jr. University Hospital has received a national Rising Star Quality Leadership award from the University HealthSystem Consortium for its quality and safety efforts.

7 Oct 2015

Anti-coagulant medications quickly resolve blood clots that could impair valve motion

Heart valve replacements made from tissue (bioprosthetic valves) have long been thought to be spared the complication of blood clot formation. Researchers have now found that about 15 percent of all bioprosthetic aortic heart valve patients develop blood clots on the leaflets affecting valve opening, regardless of whether the patient received the new valve via open-heart surgery or a minimally-invasive catheter procedure, a new study from the Cedars-Sinai Heart Institute shows.

6 Oct 2015

Medinol announces completion of enrollment in BIONICS trial to evaluate effectiveness of eDES

Medinol, a developer of Interventional Cardiology devices, announced today the completion of enrollment in its BIONICS trial, a global, prospective, randomized, multicenter, clinical trial designed to evaluate the safety and effectiveness of a new Coronary Stent System, the first ever elastomeric Drug Eluting Stent or eDES.

22 Sep 2015

Acute Cardiovascular Care 2015 to be held in Vienna from 17 to 19 October

Acute Cardiovascular Care 2015 will highlight innovations and controversies in the field, guaranteeing great stories on topics relevant to the press.

18 Sep 2015

Thoratec begins SHIELD II U.S. clinical trial to examine use of HeartMate PHP in patients undergoing high-risk PCI

Thoratec Corporation, a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that it has begun enrollment in the SHIELD II U.S. clinical trial examining the HeartMate PHP in patients undergoing a high-risk PCI (percutaneous coronary intervention) procedure.

4 Sep 2015

Loyola implants new percutaneous aortic heart valve that does not require open surgery

Loyola University Medical Center is the first center in Illinois to implant a new percutaneous aortic heart valve that does not require open heart surgery.

19 Aug 2015

Mount Sinai launches clinical trial to test effectiveness of ticagrelor drug in treating coronary stent patients

The Icahn School of Medicine at Mount Sinai has launched an international clinical trial called TWILIGHT to test the safety and effectiveness of treating coronary stent patients with the anti-clotting medication ticagrelor alone, instead of combining it with aspirin, which is the current standard of care. Researchers will analyze the potential benefits of administering ticagrelor to reduce clotting while at the same time reducing the risk of bleeding associated with the use of both medications.

12 Aug 2015